Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Palmetto Issues Final LCD for DermTech Pigmented Lesion Assay

Palmetto Issues Final LCD for DermTech Pigmented Lesion Assay

Jan 02, 2020
|
staff reporter

NEW YORK – Dermatology genomics testing company DermTech said on Thursday that Medicare Administrative Contractor Palmetto GBA MolDx has issued a final local coverage determination for the company's Pigmented Lesion Assay (PLA).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Teasing Out How Infections Spread

The Chan Zuckerberg Biohub is working with California's health department to sequence viral samples from COVID-19 patients to trace viral introductions, according to the San Francisco Chronicle.

How Far the Butterfly Flies

Despite differences in their migration habits, eastern and western monarch butterflies are genetically similar, according to a study in Molecular Ecology.

Fast COVID-19 Testing for UK

The UK is implementing COVID-19 testing with a 90-minute turnaround time.

PLOS Papers on Mycetoma Molecular Epidemiology, Campylobacter in Retail Meat, More

In PLOS this week: identification of fungal species in subcutaneous infections, sequencing of Campylobacter found in raw meat from retail stores, and more.

What's Popular?

In Business News

  1. Exact Sciences Positions Itself as Cancer Testing Provider of Future as COVID Crisis Continues

    Premium

  2. NHS Will Roll Out COVID-19 Tests From DnaNudge, Oxford Nanopore Across UK

  3. Pacific Biosciences, Asuragen Collaborate on Clinical Assays

  4. US Appeals Court Lifts Injunction on 10x Genomics' Linked-Reads, Single-Cell CNV Assays

  5. Stupid Strong Awards City of Hope $125K for Gastric Cancer Liquid Biopsy Research

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.